132 related articles for article (PubMed ID: 21057758)
1. Therapy-related leukemia cutis after adjuvant chemotherapy in a breast cancer patient.
Lee HY; Ng HJ; Wong PC; Pang SM
Acta Derm Venereol; 2010 Nov; 90(6):649-50. PubMed ID: 21057758
[No Abstract] [Full Text] [Related]
2. Leukaemia cutis in a patient treated for breast cancer.
Weinel S; Malone J; Jain D; Callen JP
Australas J Dermatol; 2009 Feb; 50(1):52-5. PubMed ID: 19178494
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil).
Hatam N; Ahmadloo N; Ahmad Kia Daliri A; Bastani P; Askarian M
Arch Gynecol Obstet; 2011 Jul; 284(1):215-20. PubMed ID: 20740365
[TBL] [Abstract][Full Text] [Related]
4. Aleukemic monocytic leukemia cutis.
Barzilai A; Lyakhovitsky A; Goldberg I; Meytes D; Trau H
Cutis; 2002 Apr; 69(4):301-4. PubMed ID: 12080951
[TBL] [Abstract][Full Text] [Related]
5. Aleukemic leukemia cutis preceding acute monocytic leukemia: a case report.
Martínez-Poventud G; Fradera J; Pérez S; Fernández A; Pacheco E; Acabá L; López-Enriquez A; Román-Díaz A; Castro-Montalvo J; Vélez-García E
P R Health Sci J; 2008 Sep; 27(3):256-8. PubMed ID: 18782972
[TBL] [Abstract][Full Text] [Related]
6. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
Gül U; Kiliç A
Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
[No Abstract] [Full Text] [Related]
7. Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer.
Rao MV; Shayne M
Breast Cancer Res Treat; 2009 Sep; 117(1):197-8. PubMed ID: 18592371
[No Abstract] [Full Text] [Related]
8. Successful graft-versus-leukemia effect of second bone marrow transplantation on relapsed leukemia cutis that was refractory to intensive chemotherapy and donor lymphocyte transfusions in a patient with acute monocytic leukemia.
Ashida T; Kawanishi K; Ariyama T; Hamasaki H; Maeda Y; Tsubaki K; Kanamaru A
Int J Hematol; 2000 Jun; 71(4):385-8. PubMed ID: 10905060
[TBL] [Abstract][Full Text] [Related]
9. Severe palmar-plantar erythema in a patient with breast cancer receiving doxorubicin-cyclophosphamide chemotherapy.
Damasiewicz MJ; Chionh FJ; Hayes T
Intern Med J; 2007 Jul; 37(7):505-6. PubMed ID: 17547732
[No Abstract] [Full Text] [Related]
10. [Pancytopenia and macular rash in a woman with a history of breast cancer].
Jacobi D; Vidal C; Gironet N; Machet MC; Machet L
Rev Med Interne; 2003 Jun; 24(6):399-400. PubMed ID: 12814830
[No Abstract] [Full Text] [Related]
11. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
12. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
[TBL] [Abstract][Full Text] [Related]
13. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Muss HB; Berry DA; Cirrincione C; Budman DR; Henderson IC; Citron ML; Norton L; Winer EP; Hudis CA;
J Clin Oncol; 2007 Aug; 25(24):3699-704. PubMed ID: 17704418
[TBL] [Abstract][Full Text] [Related]
14. t(8;16) AML developed subsequent to breast cancer therapy.
Sahin FI; Yilmaz Z; Karakuş S; Boğa S; Akçali Z; DemIrhan B
Hematology; 2006 Jun; 11(3):153-5. PubMed ID: 17326321
[TBL] [Abstract][Full Text] [Related]
15. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.
Pedersen-Bjergaard J; Sigsgaard TC; Nielsen D; Gjedde SB; Philip P; Hansen M; Larsen SO; Rørth M; Mouridsen H; Dombernowsky P
J Clin Oncol; 1992 Sep; 10(9):1444-51. PubMed ID: 1517787
[TBL] [Abstract][Full Text] [Related]
16. Monocytic aleukemic leukemia cutis.
Török L; Lueff S; Garay G; Tápai M
J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):54-8. PubMed ID: 10565632
[TBL] [Abstract][Full Text] [Related]
17. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
19. Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.
Fornier MN; Seidman AD; Theodoulou M; Moynahan ME; Currie V; Moasser M; Sklarin N; Gilewski T; D'Andrea G; Salvaggio R; Panageas KS; Norton L; Hudis C
Clin Cancer Res; 2001 Dec; 7(12):3934-41. PubMed ID: 11751485
[TBL] [Abstract][Full Text] [Related]
20. Hand-foot syndrome in breast cancer patients receiving adjuvant chemotherapy.
Lee CK; Lynch J
Intern Med J; 2007 Apr; 37(4):281-2. PubMed ID: 17388876
[No Abstract] [Full Text] [Related]
[Next] [New Search]